Akt-2 Is a Potential Therapeutic Target for Disseminated Candidiasis.
Huang L, Ma Y, Guo H, Tang N, Ouyang S, Nuro-Gyina P, Tao L, Liu Y, O'Brien MC, Langdon WY, Zhang J.
Huang L, et al.
J Immunol. 2022 Sep 1;209(5):991-1000. doi: 10.4049/jimmunol.2101003. Epub 2022 Aug 5.
J Immunol. 2022.
PMID: 36130126
Free PMC article.